364 related articles for article (PubMed ID: 22672182)
1. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
2. HIV-associated Kaposi sarcoma in African children.
Feller L; Khammissa RA; Gugushe TS; Chikte UM; Wood NH; Meyerov R; Lemmer J
SADJ; 2010 Feb; 65(1):20-2. PubMed ID: 20411798
[TBL] [Abstract][Full Text] [Related]
3. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
4. Facial lymphoedema as an indicator of terminal disease in oral HIV-associated Kaposi sarcoma.
Feller L; Khammissa RA; Wood NH; Jose RJ; Lemmer J
SADJ; 2010 Feb; 65(1):14, 16-8. PubMed ID: 20411797
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report.
Feller L; Anagnostopoulos C; Wood NH; Bouckaert M; Raubenheimer EJ; Lemmer J
J Periodontol; 2008 Feb; 79(2):362-8. PubMed ID: 18251652
[TBL] [Abstract][Full Text] [Related]
6. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
Kalpidis CD; Lysitsa SN; Lombardi T; Kolokotronis AE; Antoniades DZ; Samson J
J Periodontol; 2006 Mar; 77(3):523-33. PubMed ID: 16512768
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma in sub-Saharan Africa: a current perspective.
Mosam A; Aboobaker J; Shaik F
Curr Opin Infect Dis; 2010 Apr; 23(2):119-23. PubMed ID: 19996745
[TBL] [Abstract][Full Text] [Related]
8. Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
Dalla Pria A; Hayward K; Bower M
Expert Rev Anticancer Ther; 2013 Feb; 13(2):203-9. PubMed ID: 23406561
[TBL] [Abstract][Full Text] [Related]
9. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
10. New drug targets in Kaposi sarcoma.
Sullivan RJ; Pantanowitz L
Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous HIV-associated Kaposi sarcoma: a potential setting for management by clinical observation.
Beatrous SV; Grisoli SB; Riahi RR; Cohen PR
Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633734
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
13. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
14. Facing up to the ongoing challenge of Kaposi's sarcoma.
Robey RC; Bower M
Curr Opin Infect Dis; 2015 Feb; 28(1):31-40. PubMed ID: 25490104
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
16. Unknown: Unusual exophytic nodule on the plantar foot.
Chambers C; Sharon V; Fazel N
Dermatol Online J; 2010 Apr; 16(4):11. PubMed ID: 20409418
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
[TBL] [Abstract][Full Text] [Related]
18. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.
Leidner RS; Aboulafia DM
AIDS Patient Care STDS; 2005 Oct; 19(10):635-44. PubMed ID: 16232048
[TBL] [Abstract][Full Text] [Related]
19. Acquired immune deficiency syndrome-related epidemic Kaposi sarcoma.
Steuer AB; Cohen JM; Christman MP; Penn LA; Brinster N; Femia AN
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677797
[TBL] [Abstract][Full Text] [Related]
20. Histological features of kaposi sarcoma in a patient receiving highly active antiviral therapy.
Eng W; Cockerell CJ
Am J Dermatopathol; 2004 Apr; 26(2):127-32. PubMed ID: 15024195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
